Charles ChaseVP, Technical Business Development at AsymchemSpeaker
Profile
Chuck currently holds the role of the Vice President of Technical Business Development at Asymchem. Before joining Asymchem, he served as Vice President of Pharmaceutical Development at Elicio Therapeutics and Senior Principal Scientist at Eisai Inc. With experience spanning over 25 years in Chemistry, Manufacturing, and Controls (CMC), he possesses a deep understanding of process research and development across various substances, including oligonucleotides, peptides, and complex small molecules like Halaven®. His expertise encompasses synthesis, route optimization, CMC/CDMO management, and navigating regulatory approval processes.
Agenda Sessions
Fragment Based Ligation for Rapid Oligonucleotide Synthesis
, 3:00pmView Session